283 related articles for article (PubMed ID: 27502833)
1. A/T Run Geometry of B-form DNA Is Independent of Bound Methyl-CpG Binding Domain, Cytosine Methylation and Flanking Sequence.
Chia JY; Tan WS; Ng CL; Hu NJ; Foo HL; Ho KL
Sci Rep; 2016 Aug; 6():31210. PubMed ID: 27502833
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 binding to DNA depends upon hydration at methyl-CpG.
Ho KL; McNae IW; Schmiedeberg L; Klose RJ; Bird AP; Walkinshaw MD
Mol Cell; 2008 Feb; 29(4):525-31. PubMed ID: 18313390
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
[TBL] [Abstract][Full Text] [Related]
4. Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain.
Lei M; Tempel W; Chen S; Liu K; Min J
Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194409. PubMed ID: 31356990
[TBL] [Abstract][Full Text] [Related]
5. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
Ballestar E; Yusufzai TM; Wolffe AP
Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
[TBL] [Abstract][Full Text] [Related]
6. Binding Analysis of Methyl-CpG Binding Domain of MeCP2 and Rett Syndrome Mutations.
Yang Y; Kucukkal TG; Li J; Alexov E; Cao W
ACS Chem Biol; 2016 Oct; 11(10):2706-2715. PubMed ID: 27356039
[TBL] [Abstract][Full Text] [Related]
7. Influence of the disordered domain structure of MeCP2 on its structural stability and dsDNA interaction.
Ortega-Alarcon D; Claveria-Gimeno R; Vega S; Jorge-Torres OC; Esteller M; Abian O; Velazquez-Campoy A
Int J Biol Macromol; 2021 Apr; 175():58-66. PubMed ID: 33548325
[TBL] [Abstract][Full Text] [Related]
8. Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain.
Galvão TC; Thomas JO
Nucleic Acids Res; 2005; 33(20):6603-9. PubMed ID: 16314321
[TBL] [Abstract][Full Text] [Related]
9. The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome.
Nan X; Bird A
Brain Dev; 2001 Dec; 23 Suppl 1():S32-7. PubMed ID: 11738839
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation in the gene body influences MeCP2-mediated gene repression.
Kinde B; Wu DY; Greenberg ME; Gabel HW
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.
Ohki I; Shimotake N; Fujita N; Jee J; Ikegami T; Nakao M; Shirakawa M
Cell; 2001 May; 105(4):487-97. PubMed ID: 11371345
[TBL] [Abstract][Full Text] [Related]
12. Tyr120Asp mutation alters domain flexibility and dynamics of MeCP2 DNA binding domain leading to impaired DNA interaction: Atomistic characterization of a Rett syndrome causing mutation.
D'Annessa I; Gandaglia A; Brivio E; Stefanelli G; Frasca A; Landsberger N; Di Marino D
Biochim Biophys Acta Gen Subj; 2018 May; 1862(5):1180-1189. PubMed ID: 29428602
[TBL] [Abstract][Full Text] [Related]
13. DNA binding restricts the intrinsic conformational flexibility of methyl CpG binding protein 2 (MeCP2).
Hansen JC; Wexler BB; Rogers DJ; Hite KC; Panchenko T; Ajith S; Black BE
J Biol Chem; 2011 May; 286(21):18938-48. PubMed ID: 21467044
[TBL] [Abstract][Full Text] [Related]
14. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).
Valinluck V; Tsai HH; Rogstad DK; Burdzy A; Bird A; Sowers LC
Nucleic Acids Res; 2004; 32(14):4100-8. PubMed ID: 15302911
[TBL] [Abstract][Full Text] [Related]
15. Methyl-CpG binding proteins in the nervous system.
Fan G; Hutnick L
Cell Res; 2005 Apr; 15(4):255-61. PubMed ID: 15857580
[TBL] [Abstract][Full Text] [Related]
16. Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions.
Ghosh RP; Horowitz-Scherer RA; Nikitina T; Gierasch LM; Woodcock CL
J Biol Chem; 2008 Jul; 283(29):20523-34. PubMed ID: 18499664
[TBL] [Abstract][Full Text] [Related]
17. Complete Profiling of Methyl-CpG-Binding Domains for Combinations of Cytosine Modifications at CpG Dinucleotides Reveals Differential Read-out in Normal and Rett-Associated States.
Buchmuller BC; Kosel B; Summerer D
Sci Rep; 2020 Mar; 10(1):4053. PubMed ID: 32132616
[TBL] [Abstract][Full Text] [Related]
18. MeCP2 and other methyl-CpG binding proteins.
Jørgensen HF; Bird A
Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the interaction between MeCP2 methyl-CpG binding domain and methylated DNA by single molecule force spectroscopy.
Qin J; Zhang M; Guan Y; Li C; Ma X; Rankl C; Tang J
Anal Chim Acta; 2020 Aug; 1124():52-59. PubMed ID: 32534675
[TBL] [Abstract][Full Text] [Related]
20. Molecular Context-Dependent Effects Induced by Rett Syndrome-Associated Mutations in MeCP2.
Ortega-Alarcon D; Claveria-Gimeno R; Vega S; Jorge-Torres OC; Esteller M; Abian O; Velazquez-Campoy A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33182787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]